SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing

Syneurx Announces Oral Covid 19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion Of Fda Phase Ii Testing

Facebook Comments

Leave a Reply

CommentLuv badge